A new anti-oestrogenic agent in late breast cancer. An early clinical appraisal of ICI46474
- PMID: 5115829
- PMCID: PMC2008453
- DOI: 10.1038/bjc.1971.33
A new anti-oestrogenic agent in late breast cancer. An early clinical appraisal of ICI46474
Abstract
An introductory clinical trial of the anti-oestrogenic agent IC146474 in late or recurrent carcinoma of the breast is described.Forty-six patients have been treated, of whom 10 have shown a good response. This is of the same order as that seen with oestrogens and androgens.The particular advantage of this drug is the low incidence of troublesome side effects.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
